X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1533) 1533
Publication (132) 132
Book Chapter (30) 30
Book Review (14) 14
Conference Proceeding (3) 3
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1185) 1185
hematology (1047) 1047
transplantation (961) 961
index medicus (916) 916
male (822) 822
female (788) 788
adult (723) 723
middle aged (719) 719
bone-marrow-transplantation (658) 658
transplantation, homologous (596) 596
transplantation conditioning - methods (594) 594
oncology (589) 589
immunology (556) 556
hematopoietic stem cells (495) 495
stem cells (495) 495
reduced-intensity (491) 491
aged (485) 485
versus-host-disease (465) 465
treatment outcome (429) 429
hematopoietic stem cell transplantation - methods (401) 401
reduced-intensity conditioning (393) 393
adolescent (391) 391
hematopoietic stem cell transplantation (348) 348
stem-cell transplantation (344) 344
retrospective studies (307) 307
young adult (281) 281
hematology, oncology and palliative medicine (276) 276
reduced intensity conditioning (267) 267
health aspects (256) 256
care and treatment (252) 252
acute myeloid-leukemia (248) 248
hematopoietic stem cell transplantation - adverse effects (248) 248
transplantation conditioning (240) 240
mortality (236) 236
leukemia (227) 227
risk factors (227) 227
survival analysis (226) 226
disease-free survival (221) 221
chemotherapy (211) 211
vidarabine - analogs & derivatives (209) 209
stem cell transplantation (204) 204
child (203) 203
recurrence (198) 198
graft vs host disease - prevention & control (194) 194
unrelated donors (194) 194
cancer (193) 193
hematologic malignancies (193) 193
analysis (184) 184
therapy (173) 173
bone marrow (172) 172
allogeneic stem cell transplantation (171) 171
fludarabine (167) 167
graft vs host disease - etiology (166) 166
research (162) 162
leukemia, myeloid, acute - therapy (156) 156
child, preschool (155) 155
survival (155) 155
patient outcomes (154) 154
allogeneic transplantation (153) 153
hematologic neoplasms - therapy (148) 148
survival rate (146) 146
blood (145) 145
acute myelogenous leukemia (144) 144
prognosis (143) 143
total-body irradiation (140) 140
article (138) 138
follow-up studies (133) 133
acute myeloid leukemia (129) 129
vidarabine - administration & dosage (128) 128
children (124) 124
myelodysplastic syndrome (122) 122
remission induction (121) 121
transplantation conditioning - adverse effects (121) 121
relapse (119) 119
reduced intensity (112) 112
antineoplastic combined chemotherapy protocols - therapeutic use (110) 110
chimerism (110) 110
infant (110) 110
minimal residual disease (110) 110
pediatrics (110) 110
graft vs host disease - mortality (109) 109
1st complete remission (104) 104
conditioning regimen (104) 104
t cells (104) 104
bone marrow transplantation (102) 102
hematopoietic stem cell transplantation - mortality (101) 101
outcomes (99) 99
cyclophosphamide (97) 97
tissue donors (95) 95
prospective studies (94) 94
graft (92) 92
risk (92) 92
alemtuzumab (91) 91
hemic and lymphatic diseases (90) 90
leukemia, myeloid, acute - mortality (90) 90
busulfan (89) 89
diagnosis (89) 89
transplantation chimera (89) 89
graft-versus-host disease (88) 88
medicine & public health (88) 88
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1518) 1518
French (19) 19
Japanese (9) 9
German (5) 5
Polish (3) 3
Russian (3) 3
Spanish (3) 3
Korean (2) 2
Czech (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 02/2013, Volume 119, Issue 3, pp. 602 - 611
Journal Article
Haematologica, ISSN 0390-6078, 02/2012, Volume 97, Issue 2, pp. 310 - 317
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2013, Volume 19, Issue 1, pp. 117 - 122
Abstract Fifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploidentical bone marrow transplantation (BMT), followed by... 
Hematology, Oncology and Palliative Medicine | Haploidentical transplantations | Acute leukemia | HLA | Posttransplantation cyclophosphamide | Allogeneic stem cell transplant | MORTALITY | IMMUNOLOGY | RECIPIENTS | VERSUS-HOST-DISEASE | TRANSPLANTATION | REDUCED-INTENSITY | ACUTE-LEUKEMIA | HIGH-RISK | HAPLOTYPE | OUTCOMES | STEM-CELL TRANSPLANTATION | HEMATOLOGY | BLOOD | Hematologic Neoplasms - therapy | Whole-Body Irradiation | Cyclophosphamide - administration & dosage | Follow-Up Studies | Myeloablative Agonists - adverse effects | Thiotepa - administration & dosage | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Busulfan - administration & dosage | Cyclophosphamide - adverse effects | Transplantation, Homologous | Graft vs Host Disease - mortality | Antineoplastic Agents - adverse effects | Bone Marrow Transplantation | Adult | Female | Retrospective Studies | Graft vs Host Disease - etiology | Immunosuppressive Agents - administration & dosage | Acute Disease | Busulfan - adverse effects | Vidarabine - adverse effects | Survival Rate | Vidarabine - analogs & derivatives | Disease-Free Survival | Adolescent | Myeloablative Agonists - administration & dosage | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Aged | Vidarabine - administration & dosage | Transplantation Conditioning | Chronic Disease | Thiotepa - adverse effects | Antimitotic agents | Pneumonia | Cyclophosphamide | Bacterial pneumonia | Mortality | Bone marrow | Transplantation | Antineoplastic agents | Cancer
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 05/2015, Volume 62, Issue 5, pp. 883 - 889
Background The relative efficacy of allogeneic hematopoietic cell transplantation (allo‐HCT) after reduced toxicity conditioning (RTC) compared with standard... 
hematopoietic stem cell transplantation | acute myeloid leukemia | childhood | reduced intensity conditioning | melphalan | reduced toxicity conditioning | Reduced intensity conditioning | Reduced toxicity conditioning | Acute myeloid leukemia | Hematopoietic stem cell transplantation | Childhood | Melphalan | AML | LATE COMPLICATIONS | ONCOLOGY-GROUP | MARROW | INTENSITY | REGIMENS | SIBLING DONORS | ALLOGENEIC HEMATOPOIETIC SCT | ONCOLOGY | HOST-DISEASE | PEDIATRICS | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Whole-Body Irradiation | Graft vs Host Disease - epidemiology | Prognosis | Follow-Up Studies | Humans | Child, Preschool | Infant | Male | Neoplasm Recurrence, Local - mortality | Busulfan - administration & dosage | Transplantation, Homologous | Graft vs Host Disease - mortality | Female | Retrospective Studies | Child | Graft vs Host Disease - diagnosis | Infant, Newborn | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - pathology | Japan | Hematopoietic Stem Cell Transplantation | Survival Rate | Combined Modality Therapy | Neoplasm Recurrence, Local - diagnosis | Vidarabine - analogs & derivatives | Remission Induction | Leukemia, Myeloid, Acute - mortality | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Recurrence, Local - epidemiology | Vidarabine - administration & dosage | Transplantation Conditioning | Neoplasm Staging | Antimitotic agents | Mortality | Radiation | Transplantation | Children | Comparative analysis | Antineoplastic agents | Health aspects | Hematopoietic stem cells | Adolescence | Graft-versus-host reaction | Pediatrics | Transplants & implants | Toxicity | Complications | Myeloid leukemia | Leukemia | Clinical trials | Patients | Hemopoiesis | Demographics | Fludarabine | Irradiation | Remission | Busulfan | Conditioning | Adolescents | Cancer | Index Medicus
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 01/2017, Volume 23, Issue 1, pp. 53 - 59
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 4, pp. 698 - 704
Abstract Myeloablative conditioning and allogeneic hematopoietic stem cell transplant (alloHSCT) in children with acute myeloid leukemia (AML) in first... 
Hematology, Oncology and Palliative Medicine | Reduced-intensity conditioning | Allogeneic stem cell transplantation | Gemtuzumab ozogamicin | Pediatric AML | Immunotherapy | ONCOLOGY-GROUP | EVENT-FREE SURVIVAL | BONE-MARROW-TRANSPLANTATION | IMMUNOLOGY | VERSUS-HOST-DISEASE | NONMALIGNANT DISEASES | TRANSPLANTATION | PEDIATRIC RECIPIENTS | UMBILICAL-CORD BLOOD | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | MYCOPHENOLATE-MOFETIL | CLINICAL-SIGNIFICANCE | Myeloablative Agonists - therapeutic use | Immunotherapy - methods | Consolidation Chemotherapy - methods | Humans | Immunosuppressive Agents - therapeutic use | Sialic Acid Binding Ig-like Lectin 3 - immunology | Child, Preschool | Male | Leukemia, Myeloid, Acute - immunology | Graft vs Host Disease - immunology | Transplantation, Homologous | Young Adult | Graft vs Host Disease - mortality | Antilymphocyte Serum - therapeutic use | Female | Unrelated Donors | Transplantation Conditioning - methods | Child | Leukemia, Myeloid, Acute - therapy | Siblings | Antibodies, Monoclonal, Humanized - therapeutic use | Busulfan - therapeutic use | Drug Administration Schedule | Leukemia, Myeloid, Acute - pathology | Hematopoietic Stem Cell Transplantation | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Graft vs Host Disease - pathology | Leukemia, Myeloid, Acute - mortality | Immunotoxins - therapeutic use | Adolescent | Survival Analysis | Graft vs Host Disease - prevention & control | Aminoglycosides - therapeutic use | Index Medicus
Journal Article
American Journal of Hematology, ISSN 0361-8609, 01/2017, Volume 92, Issue 1, pp. 18 - 22
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 10, pp. 1808 - 1815
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 01/2019, Volume 25, Issue 1, pp. 73 - 85
The combination of a calcineurin inhibitor (CNI) such as tacrolimus (TAC) or cyclosporine (CYSP) with methotrexate (MTX) or with mycophenolate mofetil (MMF)... 
Graft-versus-host disease prophylaxis | Allogeneic hematopoietic cell transplantation | Reduced-intensity conditioning | Calcineurin inhibitor Tacrolimus | Cyclosporine | Mycophenolate mofetil | Methotrexate | COMPARING METHOTREXATE | BONE-MARROW | IMMUNOLOGY | TRANSPLANTATION | TRIAL | GVHD PROPHYLAXIS | STEM-CELL TRANSPLANTATION | TACROLIMUS | HEMATOLOGY | BLOOD
Journal Article